ABSTRACT
. In this study we fed choline-deficient diets to normal humans, and report changes in the choline and phosphatidylcholine content of blood and in liver function.
METHODS

Subjects
Sixteen healthy male volunteers were recruited for this study with their informed consent. Serum directbilirubin, mol/liter 2.6 (± 0.7) (Fig. 2) . In the control group, plasma phosphatidylcholine remained relatively constant between days 7 and 35 (91-100% of day 7; Fig. 2 ). In the cholinedeficient group, plasma phosphatidylcholine decreased approximately 30% on the average during the 3-wk period when a choline-deficient diet was ingested ( Fig. 2; 
but this is seen only when exogenous S-adenosylmethionine is added to the incubation mixture (23). The FASEB Journal ZEISEL ET AL.
experimental diet control or choline deficient Figure   1 . Plasma choline in humans ingesting a control or cholinedeficient diet. Healthy male subjects were hospitalized for 5 wk. During the first and last weeks of the study, all subjects consumed an identical choline-containing standard diet; during the middle 3 wk of the study subjects were divided into two groups: one that continued on the choline-containing diet, and one that consumed the same diet without choline. During the 5th wk of the study all subjects consumed the choline-containing diet. Plasma choline was measured using a mass spectrometric method. Data are expressed as mean choline concentration (Mmol/liter) ± SEM . , P < 0.01 different from day 7 value.
Days
Renal function, which was assessed using urinalysis, microscopic examination of urine, urine creatinine, serum creatinine, and blood urea nitrogen measurements did not change in either group during the study.
DISCUSSION
We designed the study to assess the effects of removing choline from the diet on three outcome measures. Plasma choline, plasma, and erythrocyte phosphatidylcholine were measured because they reflect the choline and choline ester content of tissues; serum ALT activity is the most commonly used clinical test for detecting liver injury. We observed that humans ingesting a choline-deficient diet for 3 wk had diminished plasma choline and phosphatidylcholine concentrations ( Fig. 1 and Fig. 2 ) as well as diminished erythrocyte membrane phosphatidylcholine concentrations. Serum ALT activity increased significantly during the period when a choline-deficient diet was ingested (Fig. 3) . The design of the study, as approved by our Institutional Review Board, was such that clinically significant changes in liver function (ALT activity exceeding 0.58 ikat/liter) were not to be induced in the subjects.
We suggest that choline deficiency of longer duration would have resulted in more prominent evidence of liver dysfunction (Fig. 3) . Demands for choline are much 
35
The demand for choline as a methyl donor is probably the major factor that determines how rapidly a diet deficient in choline will induce pathology.
Our diet delivered the recommended daily allowance of methionine and folate. It is possible that if methionine were provided in larger amounts, the effects of removing choline from the diet would be moderated or eliminated. This is the case for adult rats (1) . has not yet been performed.
Our study of normal humans suggests that such an experiment would be worthwhile. In summary, we observed that when healthy humans consume a diet deficient in choline for 3 wk they deplete stores of choline in plasma and develop signs that suggest incipient liver dysfunction.
It is likely that the demand for choline in humans will be influenced by the availability of methionine and folate in the diet. Our observations support the conclusion that choline is an essential nutrient for humans when excess methionine and folate are not available in the diet.
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